1.7 Flashcards

1
Q

Repeated phlebotomy in patients with polycythemia vera (PV) may lead to the development of:

A. Folic acid deficiency
B. Sideroblastic anemia
C. Iron deficiency anemia
D. Hemolytic anemia

A

C. Iron deficiency anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

In essential thrombocythemia, the platelets are:

A. Increased in number and functionally abnormal
B. Normal in number and functionally abnormal
C. Decreased in number and functional
D. Decreased in number and functionally abnormal

A

A. Increased in number and functionally abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following cells is considered pathognomonic for Hodgkin’s disease?

A. Niemann-Pick cells
B. Reactive lymphocytes
C. Flame cells
D. Reed-Sternberg cells

A

D. Reed-Sternberg cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In myelofibrosis, the characteristic abnormal red blood cell morphology is that of:

A. Target cells
B. Schistocytes
C. Teardrop cells
D. Ovalocytes

A

C. Teardrop cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PV is characterized by:

A. Increased plasma volume
B. Pancytopenia
C. Decreased oxygen saturation
D. Absolute increase in total red cell mass

A

D. Absolute increase in total red cell mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of secondary polycythemia include all of the following except:

A. Splenomegaly
B. Decreased oxygen saturation
C. Increased red cell mass
D. Increased erythropoietin

A

A. Splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The erythrocytosis seen in relative polycythemia occurs because of:

A. Decreased arterial oxygen saturation
B. Decreased plasma volume of circulating blood
C. Increased erythropoietin levels
D. Increased erythropoiesis in the bone marrow

A

B. Decreased plasma volume of circulating blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In PV, what is characteristically seen in the peripheral blood?

A. Panmyelosis
B. Pancytosis
C. Pancytopenia
D. Panhyperplasia

A

B. Pancytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The leukocyte alkaline phosphatase (LAP) stain on a patient gives the following results
10(0) 48(1+) 38(2+) 3(3+) 1(4+)
Calculate the LAP score.

A. 100
B. 117
C. 137
D. 252

A

C. 137

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CML is distinguished from leukemoid reaction by which of the following?

A. CML: low LAP; leukemoid: high LAP
B. CML: high LAP; leukemoid: low LAP
C. CML: high WBC; leukemoid: normal WBC
D. CML: high WBC; leukemoid: higher WBC

A

A. CML: low LAP; leukemoid: high LAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following occurs in idiopathic myelofibrosis (IMF)?

A. Myeloid metaplasia
B. Leukoerythroblastosis
C. Fibrosis of the bone marrow
D. All of these options

A

D. All of these options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What influence does the Philadelphia (Ph1) chromosome have on the prognosis of patients with chronic myelocytic leukemia?

A. It is not predictive
B.The prognosis is better if Ph1 is present
C.The prognosis is worse if Ph1 is present
D.The disease usually transforms into AML when Ph1 is present

A

B.The prognosis is better if Ph1 is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which of the following is (are) commonly found in CML?

A. Many teardrop-shaped cells
B. Intense LAP staining
C. A decrease in granulocytes
D. An increase in basophils

A

D. An increase in basophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In which of the following conditions does LAP show the least activity?

A. Leukemoid reactions
B. Idiopathic myelofibrosis
C. PV
D. CML

A

D. CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A striking feature of the peripheral blood of a patient with CML is a:

A. Profusion of bizarre blast cells
B. Normal number of typical granulocytes
C. Presence of granulocytes at different stages of development
D. Pancytopenia

A

C. Presence of granulocytes at different stages of development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following is often associated with CML but not with AML?

A. Infections
B. WBCs greater than 20.0 × 109/L
C. Hemorrhage
D. Splenomegaly

A

D. Splenomegaly

16
Q

Multiple myeloma and Waldenström’s macroglobulinemia have all the following in common except:

A. Monoclonal gammopathy
B. Hyperviscosity of the blood
C. Bence-Jones protein in the urine
D. Osteolytic lesions

A

D. Osteolytic lesions

17
Q

What is the characteristic finding seen in the peripheral smear of a patient with multiple myeloma?

A. Microcytic hypochromic cells
B. Intracellular inclusion bodies
C. Rouleaux
D. Hypersegmented neutrophils

A

C. Rouleaux

18
Q

All of the following are associated with the diagnosis of multiple myeloma except:

A. Marrow plasmacytosis
B. Lytic bone lesions
C. Serum and/or urine M component (monoclonal
protein)
D. Philadelphia chromosome

A

D. Philadelphia chromosome

19
Q

Multiple myeloma is most difficult to distinguish from:

A. Chronic lymphocytic leukemia
B. Acute myelogenous leukemia
C. Benign monoclonal gammopathy
D. Benign adenoma

A

C. Benign monoclonal gammopathy

20
Q

The pathology of multiple myeloma includes which of the following?

A. Expanding plasma cell mass
B. Overproduction of monoclonal immunoglobulins
C. Production of osteoclast activating factor (OAF) and other cytokines
D. All of these options

A

D. All of these options

21
Q

Waldenström’s macroglobulinemia is a malignancy of the:

A. Lymphoplasmacytoid cells
B. Adrenal cortex
C. Myeloblastic cell lines
D. Erythroid cell precursors

A

A. Lymphoplasmacytoid cells

22
Q

Cells that exhibit a positive stain with acid phosphatase and are not inhibited with tartaric acid are characteristically seen in:

A. Infectious mononucleosis
B. Infectious lymphocytosis
C. Hairy cell leukemia
D. T-cell acute lymphoblastic leukemia

A

C. Hairy cell leukemia

23
Q

The JAK2(V617F) mutation may be positive in all of the following chronic myeloproliferative disorders except:

A. Essential thrombocythemia
B. Idiopathic myelofibrosis
C. PV
D. CML

A

D. CML

24
Q

All of the following are major criteria for the 2008 WHO diagnostic criteria for essential thrombocythemia except:

A. Platelet count >450 × 109/L
B. Megakaryocyte proliferation with large and mature morphology, and no or little granulocyte or erythroid proliferation
C. Demonstration of JAK2(V617F) or other clonal marker
D. Sustained platelet count >600 × 109/L

A

D. Sustained platelet count >600 × 109/L